SYRS - Syros Pharmaceuticals GAAP EPS of -$1.43 misses by $0.29 revenue of $3.76M misses by $0.18M
2023-11-14 07:32:07 ET
More on Syros Pharmaceuticals
- Syros Pharmaceuticals Q3 2023 Earnings Preview
- Syros Pharmaceuticals announces job cuts, CEO change
- Seeking Alpha’s Quant Rating on Syros Pharmaceuticals
- Historical earnings data for Syros Pharmaceuticals
- Financial information for Syros Pharmaceuticals
For further details see:
Syros Pharmaceuticals GAAP EPS of -$1.43 misses by $0.29, revenue of $3.76M misses by $0.18M